Treatment of essential hypertension. Olmetec Plus fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil alone.
Treatment of essential hypertension. Olmetec Plus 40 mg/12.5 mg and 40 mg/25 mg fixed dose combinations are indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil 40 mg alone.
Treatment of essential hypertension in adults. Treatment of hypertension in children and adolescents from 6 to less than 18 years of age.
Glyxambi, fixed dose combination of empagliflozin and linagliptin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus: • to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Glyxambi do not provide adequate glycaemic control • when already being treated with the free combination of empagliflozin and linagliptin (See sections 4.2, 4.4, 4.5 and 5.1 for available data on combinations studied)
Treatment of adult patients with moderate to severe Alzheimer's disease.
Treatment of essential hypertension in adults, Coversyl Arginine Plus 5mg/1.25mg film-coated tablet is indicated in patients whose blood pressure is not adequately controlled on perindopril alone.
Melatonin 3 mg film-coated tablets are indicated for short-term treatment of jet-lag in adults.
Treatment of patients with moderate to severe Alzheimer's disease.